GPR55, a receptor considered part of the endocannabinoid system, has gained much attention in recent years because of its promising role in the modulation of neuroinflammation and the treatment of inflammatory-mediated neurological and psychiatric disorders [35]. The gene discussed is GPR55; the disease is psychiatric disorder.